KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that the Company will report third quarter 2023 financial results on Wednesday, November 8, 2023.
Conference Call and Webcast Details
The conference call can be accessed by dialing (844)-826-3035 for participants in the U.S. or Canada and (412)-317-5195 for international callers, using conference ID: 10182999. A live and archived webcast of the event can be accessed via the IR Calendar on the News/Events page of the Investors section of KORU Medical’s website at www.korumedical.com. The archived webcast will be available for six months.
About KORU Medical Systems
KORU Medical Systems develops, manufactures, and commercializes innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients around the world. The FREEDOM Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231025342856/en/
Source: KORU Medical Systems
View this news release online at:
http://www.businesswire.com/news/home/20231025342856/en
